(2S,3R)TMT-L-Tic-OH is a potent inverse agonist at the human δ-opioid receptor

European Journal of Pharmacology

Volumn 380, Issue 1, 1999, Pages

  Hosohata, Keiko ^a   Burkey, Thomas H ^a   Alfaro Lopez, Josua ^a   Hruby, Victor J ^a   Roeske, William R ^a   Yamamura, Henry I ^a  

^a Depts Pharmacol Biochem P   (United States)

Author keywords

G protein; Inverse agonist; Opioid receptor

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTREXONE; OPIATE AGONIST; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL CELL; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032831431     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00516-6     Document Type: Article

References (6)

1. Hosohata K., Burkey T.H., Alfaro-Lopez J., Varga E., Hruby V.J., Roeske W.R., Yamamura H.I. Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor. Eur. J. Pharmacol. 346:1998;111-114.
2. Liao S., Shenderovich M.D., Han Y., Hosohata K., Davis P., Qui W., Porreca F., Yamamura H.I., Hruby V.J. The stereochemical requirements of the novel δ-opioid selective dipeptide antagonist TMT-TIC. Bioorg. Med. Chem. Lett. 7:1997;3049-3052.
3. Malatynska E., Wang Y., Knapp R.J., Santoro G., Li X., Waite S., Roeske W.R., Yamamura H.I. Human δ opioid receptor: a stable cell line for functional studies of opioids. NeuroReport. 6:1995;613-616.
4. Mullaney I., Carr I.C., Milligan G. Analysis of inverse agonism at the δ opioid receptor after expression in rat 1 fibroblasts. Biochem. J. 315:1996;227-234.
5. Schiller P.W., Nguyen T.M.D., Weltrowska G., Wilkes B.C., Marsden B.J., Lemieux C., Chung N.N. Differential stereochemical requirements of μ vs. δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective antagonists. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11871-11875.
6. Schiller P.W., Weltrowska G., Schmidt R., Berezowska I., Nguyen T.M.D., Lemieux C., Chung N.N., Carpenter K.A., Wilkes B.C. Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics. J. Recept. Signal Transduction Res. 19:1999;573-588.